Hwanyoung Lee joined Stonebridge Ventures in June 2018 and is a managing director. He is an investor and business manager with 14 years of experience in bio and chemical industry. He has specialty in cell therapy, bioenergy, environmental process, medical device, and mainly covers growth equity and buyout transactions. Mr. Lee has invested in over 28 companies - his major investments include Celltrion Pharma, GL PharmTech, Changhae Ethanol and Intromedic.

Mr. Lee holds a B.S. in Applied Biology and Chemistry from Seoul National University, an M.S from POSTECH(Pohang University of Science and Technology), and an MBA from Korea University.